Evidence map›Paper›PMID 34319499›Full record

Observational studySleep & breathing = Schlaf & Atmung2022

Daytime polysomnography to perform titration for upper airway stimulation in patients with obstructive sleep apnea.

Pien F N Bosschieter, Emily Schoustra, Nico de Vries, Meerie J L Steinbusch, Kristel M Kasius, Madeline J L Ravesloot

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Sleep & breathing = Schlaf & Atmung, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Day-time split study for management of obstructive sleep apnoea: Proof of concept study.Lung India : official organ of Indian Chest Society · 2026
    Article
  2. Review
  3. Article
  4. Hypoglossal Nerve Stimulation Therapy.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Pien F N BosschieterDepartment of Otorhinolaryngology - Head and Neck Surgery , OLVG, Jan Tooropstraat 164, 1061AE, Amsterdam, the Netherlands. p.f.n.bosschieter@olvg.nl.
Emily SchoustraDepartment of Otorhinolaryngology - Head and Neck Surgery , OLVG, Jan Tooropstraat 164, 1061AE, Amsterdam, the Netherlands.
Nico de VriesDepartment of Otorhinolaryngology - Head and Neck Surgery , OLVG, Jan Tooropstraat 164, 1061AE, Amsterdam, the Netherlands.
Meerie J L SteinbuschDepartment of Otorhinolaryngology - Head and Neck Surgery , OLVG, Jan Tooropstraat 164, 1061AE, Amsterdam, the Netherlands.
Kristel M KasiusDepartment of Clinical Neurophysiology, OLVG, Amsterdam, the Netherlands.
Madeline J L RaveslootDepartment of Otorhinolaryngology - Head and Neck Surgery , OLVG, Jan Tooropstraat 164, 1061AE, Amsterdam, the Netherlands.
OLVG · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUpper airway stimulation (UAS) is an innovative treatment for patients with obstructive sleep apnea (OSA). UAS titrations are performed 3 months after activation of the device to optimize its effectiveness. In general, these titrations are performed during an in-laboratory overnight polysomnography (PSG). However, overnight titrations are expensive and can be logistically challenging because they are labor-intensive which causes shortage of sleep technicians available for night shifts. In addition, recently, overnight PSGs were postponed and canceled due to the COVID-19 pandemic. We aimed to assess the feasibility of a daytime PSG to perform titration of UAS therapy as an alternative for a conventional overnight PSG.

methodsWe performed a prospective single-center observational cohort study. Patients were included when planned for UAS titration; this was approximately 6 months after UAS activation. Data on sleep architecture, patient experience, and respiratory outcomes were collected to evaluate the feasibility. An overnight follow-up PSG 12 months after implantation was used to compare sleep architecture and therapy response.

resultsOf 23 patients, four were excluded from analysis because of technical issues during PSG. Even though patients slept significantly shorter during the daytime PSG, this was enough time to complete the titration successfully with 30-min sleep in final therapeutic settings in 84% of the patients. Patients (94%) had a positive experience with the daytime titration. Respiratory outcomes were significantly reduced during titration and were maintained at the 12-month follow-up.

conclusionDaytime titrations are a valuable alternative for conventional overnight titrations. Our findings suggest the implementation of daytime titrations as standard of care. This will contribute to easier logistics and better work circumstances for sleep technicians without jeopardizing titration quality.

Indexed as

COVID-19Sleep Apnea, ObstructiveHumansPandemicsPolysomnographyProspective StudiesDaytime polysomnographyDevice titrationObstructive sleep apneaSleep medicineUpper airway stimulation

Identifiers

PMID34319499
PMCPMC8316890
OpenAlexW3186991375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.